← The Wire
UNCYNasdaq
Unicycive Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1766140
Developing and commercializing innovative therapies, initially for kidney disease
red 8-K · 90d
$199M
Market cap
$7.70
Last close
+8.0%
1D
-2.2%
5D
2.6M
Volume
Price · last 39 sessions-3.5%
May 4L $6.66 · H $8.56Jun 29
123
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
DEFA14ACURRENT REPORTJun 22, 20268-KShareholder VoteJun 22, 20268-KMaterial AgreementJun 5, 20268-KResults of OperationsMay 12, 202610-QQUARTERLY REPORTMay 12, 2026DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 30, 2026DEF 14ADEFINITIVE PROXY STATEMENTApr 30, 20268-KExecutive ChangeApr 6, 20268-KResults of OperationsMar 30, 202610-KANNUAL REPORTMar 30, 20268-KCompany UpdateNov 14, 2025424B5PROSPECTUS SUPPLEMENTNov 14, 20258-KResults of OperationsNov 12, 202510-QQUARTERLY REPORTNov 12, 20258-KResults of Operations · Company UpdateOct 28, 20258-KCompany UpdateAug 18, 20258-KCompany UpdateAug 15, 20258-KResults of OperationsAug 14, 202510-QQUARTERLY REPORTAug 14, 20258-KCompany UpdateJul 8, 20258-KResults of Operations · Company UpdateJun 30, 20258-KSecurity-Holder Rights · Bylaw AmendmentJun 20, 2025424B5PROSPECTUS SUPPLEMENTJun 13, 20258-KCompany UpdateJun 10, 2025DEFA14ACURRENT REPORTJun 9, 20258-KShareholder VoteJun 9, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 22, 2025DEFA14ACURRENT REPORTMay 21, 20258-KCompany UpdateMay 21, 20258-KResults of OperationsMay 14, 202510-QQUARTERLY REPORTMay 14, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 7, 2025DEF 14ADEFINITIVE PROXY STATEMENTApr 30, 20258-K/AMaterial Agreement · Equity IssuanceApr 14, 20258-KResults of OperationsMar 31, 202510-KANNUAL REPORTMar 31, 20258-KCompany UpdateJan 7, 2025SC 13GSC 13GNov 13, 20248-KResults of OperationsNov 13, 202410-QQUARTERLY REPORTNov 13, 20248-KCompany UpdateNov 12, 2024SC 13GSC 13GOct 11, 20248-KCompany UpdateSep 25, 20248-KResults of OperationsAug 14, 202410-QQUARTERLY REPORTAug 14, 2024SC 13GSC 13GJul 18, 20248-KDelisting NoticeJul 15, 20248-KDelisting NoticeJul 15, 20248-KMaterial AgreementJul 2, 20248-KBylaw AmendmentJun 26, 20248-KReg FD DisclosureJun 25, 20248-KShareholder VoteJun 20, 20248-KResults of OperationsMay 13, 202410-QQUARTERLY REPORTMay 13, 2024DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 8, 2024DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 26, 2024DEF 14ADEFINITIVE PROXY STATEMENTApr 26, 20248-KResults of OperationsMar 29, 202410-KANNUAL REPORTMar 28, 20248-KMaterial Agreement · Equity IssuanceMar 14, 20248-KMaterial Agreement · Equity IssuanceMar 14, 20248-KCompany UpdateFeb 21, 2024SC 13GSC 13GFeb 5, 2024SC 13GSC 13GJan 22, 20248-KResults of OperationsNov 14, 202310-QQUARTERLY REPORTNov 14, 20238-KCompany UpdateOct 23, 20238-KDelisting NoticeSep 25, 20238-KExecutive Change · Company UpdateSep 6, 20238-KAuditor ChangeAug 31, 20238-KResults of OperationsAug 15, 202310-QQUARTERLY REPORTAug 14, 20238-KAuditor ChangeJul 31, 20238-KCompany UpdateJul 26, 2023SC 13GSCHEDULE 13GJul 14, 2023SC 13GSCHEDULE 13GJul 6, 2023SC 13GSC 13GJul 6, 20238-KCompany UpdateJun 30, 20238-KShareholder VoteJun 26, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSJun 13, 2023
Similar companies
Comparable business profile · signals at a glance